
Oxon Drugs Private Limited
About Oxon Drugs Private Limited
Data last updated:
Oxon Drugs Private Limited is a private limited company based in Jagadhri, Haryana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 23 March 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21002HR2023PTC110171. Its GSTIN is 06AAECO0173B1Z0 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin and Rohit Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 17, Jagadhri, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.61 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹69,607 (net margin 1.1%) and EBITDA of ₹1.24 Lakh (EBITDA margin 2%).
Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.
Company details
Contact details
Oxon Drugs Private Limited's registered office is in Jagadhri, Haryana.
- Registered AddressSCO No. 40, Sector 17 HUDA, Jagadhri, Haryana, India – 135003
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxon Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Oxon Drugs Private Limited, buy the company report.
Financials of Oxon Drugs Private Limited
FY 2025 filings availableOxon Drugs Private Limited reported revenue of ₹60.61 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year. EBITDA rose 24% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.24 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹69,607 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2% | ||
| Net Profit Margin | 1.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Oxon Drugs Private Limited, buy the company report.
Board of directors of Oxon Drugs Private Limited
Oxon Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin | Director | 09 Apr 2024 | 2 Years 7 Months | Current |
| Rohit Singh | Director | 23 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Oxon Drugs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Talegaon Dhamdhere Agrotech Producer Company Limited | ₹60.79 Lakh (FY 2025) | 34.0% | Shirur, Maharashtra, India | |||
| Ether Vibration Agrotech Private Limited | ₹60.76 Lakh (FY 2025) | 2.0% | Raigad, Maharashtra, India | |||
| Aimers Consultancy Private Limited | ₹60.73 Lakh (FY 2025) | 2549.0% | Noida, Uttar Pradesh, India | |||
| Akimoto Pharmaceuticals Private Limited | ₹60.66 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Ecom Buddy International Private Limited | ₹60.65 Lakh (FY 2025) | 254.0% | Delhi, India | |||
| Oxon Drugs Private Limitedthis company | ₹60.61 Lakh (FY 2025) | ₹69,607 | 1.1% | 4.0% | Jagadhri, Haryana, India | |
| Caroline Furnishers Private Limited | ₹60.48 Lakh (FY 2025) | -38.0% | Mumbai, Maharashtra, India | |||
| Jupiter Mineral Trading Private Limited | ₹60.42 Lakh (FY 2025) | Visakhapatnam, Andhra Pradesh, India | ||||
| Soruka Private Limited | ₹60.42 Lakh (FY 2025) | -4.0% | New Delhi, Delhi, India | |||
| Attar Finance and Investment Company Pvt Ltd | ₹60.4 Lakh (FY 2025) | -97.0% | Mumbai, Maharashtra, India | |||
| Shharda Pet India Private Limited | ₹60.4 Lakh (FY 2025) | Pune, Maharashtra, India |
To see the full peer comparison of Oxon Drugs Private Limited, buy the company report.
Legal cases
Oxon Drugs Private Limited has 4 court cases on record: 4 filed by Oxon Drugs. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yamunanagar, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against individuals | Pending |
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against individuals | Pending |
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against Nagar Pharma Baran and 1 other | Disposed |
To see the full case history of Oxon Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxon Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxon Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECO0173B1Z0 | Haryana | Active | 09 Apr 2023 |
To see the full GST registrations and return filing status of Oxon Drugs Private Limited, buy the company report.
Recent activity
Oxon Drugs Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Sachin ceased to be Additional Director on 16 Dec 2024.
Frequently asked questions
Oxon Drugs is an active private limited company based in Jagadhri, Haryana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 23 March 2023 (3+ years old) and is registered under CIN U21002HR2023PTC110171.
Oxon Drugs has 2 current directors:
- Sachin - Director
- Rohit Singh - Director
The latest financial statements of Oxon Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Oxon Drugs is 06AAECO0173B1Z0, registered in Haryana.
The CIN (Corporate Identification Number) of Oxon Drugs is U21002HR2023PTC110171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxon Drugs has 4 court cases on record: 4 filed by the company. 3 are pending.
Oxon Drugs was incorporated on 23 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Oxon Drugs by revenue are Talegaon Dhamdhere Agrotech Producer Company Limited, Ether Vibration Agrotech Private Limited, Aimers Consultancy Private Limited, Akimoto Pharmaceuticals Private Limited, Ecom Buddy International Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Sachin ceased to be Additional Director on 16 Dec 2024. Sandeep Kumar ceased to be Director on 11 Jun 2024. Sachin was appointed as Director on 09 Apr 2024. Oxon Drugs has 4 board changes on record in total.
The registered office of Oxon Drugs is at SCO No. 40, Sector 17 HUDA, Jagadhri, Haryana, India – 135003.
Oxon Drugs operates in the paper industry, in the paper and paper products segment.

